233 related articles for article (PubMed ID: 31326279)
1. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
[TBL] [Abstract][Full Text] [Related]
2. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
[TBL] [Abstract][Full Text] [Related]
3. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
[TBL] [Abstract][Full Text] [Related]
4. Rare variants in the TREX1 gene and susceptibility to autoimmune diseases.
Barizzone N; Monti S; Mellone S; Godi M; Marchini M; Scorza R; Danieli MG; D'Alfonso S
Biomed Res Int; 2013; 2013():471703. PubMed ID: 24224166
[TBL] [Abstract][Full Text] [Related]
5. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
[TBL] [Abstract][Full Text] [Related]
6. MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.
Fragkioudaki S; Nezos A; Souliotis VL; Chatziandreou I; Saetta AA; Drakoulis N; Tzioufas AG; Voulgarelis M; Sfikakis PP; Koutsilieris M; Crow MK; Moutsopoulos HM; Mavragani CP
Sci Rep; 2017 Aug; 7(1):7354. PubMed ID: 28779180
[TBL] [Abstract][Full Text] [Related]
7. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
[TBL] [Abstract][Full Text] [Related]
8. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
Fabris M; Dolcetti R; Pasini E; Quartuccio L; Pontarini E; Salvin S; Ponzoni M; Scott CA; De Vita S
Clin Exp Rheumatol; 2014; 32(1):61-5. PubMed ID: 24447326
[TBL] [Abstract][Full Text] [Related]
10. Absence of somatic MYD88 L265P mutations in patients with primary Sjogren's syndrome.
Voulgarelis M; Mavragani CP; Xu L; Treon SP; Moutsopoulos HM
Genes Immun; 2014 Jan; 15(1):54-6. PubMed ID: 24153350
[TBL] [Abstract][Full Text] [Related]
11. New roles for the major human 3'-5' exonuclease TREX1 in human disease.
Kavanagh D; Spitzer D; Kothari PH; Shaikh A; Liszewski MK; Richards A; Atkinson JP
Cell Cycle; 2008 Jun; 7(12):1718-25. PubMed ID: 18583934
[TBL] [Abstract][Full Text] [Related]
12. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
[TBL] [Abstract][Full Text] [Related]
13. Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome.
Cinoku II; Verrou KM; Piperi E; Voulgarelis M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2021 Sep; 123():102704. PubMed ID: 34298409
[TBL] [Abstract][Full Text] [Related]
14. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
[TBL] [Abstract][Full Text] [Related]
15. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
16. Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjögren's syndrome.
Streubel B; Huber D; Wöhrer S; Chott A; Raderer M
Clin Cancer Res; 2004 Jan; 10(2):476-80. PubMed ID: 14760068
[TBL] [Abstract][Full Text] [Related]
17. Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands.
Hu S; Zhou M; Jiang J; Wang J; Elashoff D; Gorr S; Michie SA; Spijkervet FK; Bootsma H; Kallenberg CG; Vissink A; Horvath S; Wong DT
Arthritis Rheum; 2009 Jan; 60(1):81-92. PubMed ID: 19116902
[TBL] [Abstract][Full Text] [Related]
18. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
Van Mello NM; Pillemer SR; Tak PP; Sankar V
Ann Rheum Dis; 2005 Mar; 64(3):471-3. PubMed ID: 15708896
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
Nezos A; Mavragani CP
J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
[TBL] [Abstract][Full Text] [Related]
20. Typing TREX1 gene in patients with systemic lupus erythematosus.
Fredi M; Bianchi M; Andreoli L; Greco G; Olivieri I; Orcesi S; Fazzi E; Cereda C; Tincani A
Reumatismo; 2015 Jun; 67(1):1-7. PubMed ID: 26150267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
